These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 9304401

  • 21. Induction of mucopolysaccharidosis in rats by treatment with immunostimulatory acridine derivatives.
    Grave S, Lüllmann H, Lüllmann-Rauch R, Osterkamp G, Prokopek M.
    Toxicol Appl Pharmacol; 1992 Jun; 114(2):215-24. PubMed ID: 1609413
    [Abstract] [Full Text] [Related]

  • 22. Tilorone acts as a lysosomotropic agent in fibroblasts.
    Gupta DK, Gieselmann V, Hasilik A, von Figura K.
    Hoppe Seylers Z Physiol Chem; 1984 Aug; 365(8):859-66. PubMed ID: 6489934
    [Abstract] [Full Text] [Related]

  • 23. Matrix glycosaminoglycans in the growth phase of fibroblasts: more of the story in wound healing.
    Kosir MA, Quinn CC, Wang W, Tromp G.
    J Surg Res; 2000 Jul; 92(1):45-52. PubMed ID: 10864481
    [Abstract] [Full Text] [Related]

  • 24. Histochemical evidence for lysosomal storage of acid glycosaminoglycans in splenic cells of rats treated with tilorone.
    Lüllmann-Rauch R.
    Histochemistry; 1982 Jul; 76(1):71-87. PubMed ID: 6184348
    [Abstract] [Full Text] [Related]

  • 25. [14C]Methylamine accumulation in cultured human skin fibroblasts--a biochemical test for lysosomal storage and lysosomal diseases.
    Kopitz J, Gerhard C, Höfler P, Cantz M.
    Clin Chim Acta; 1994 Jun; 227(1-2):121-33. PubMed ID: 7955409
    [Abstract] [Full Text] [Related]

  • 26. Rhodamine B and 2-acetamido-1,3,6-tri-O-acetyl-4-deoxy-4-fluoro-D-glucopyranose (F-GlcNAc) inhibit chondroitin/dermatan and keratan sulphate synthesis by different mechanisms in bovine chondrocytes.
    Derrick-Roberts AL, Marais W, Byers S.
    Mol Genet Metab; 2012 Jun; 106(2):214-20. PubMed ID: 22546219
    [Abstract] [Full Text] [Related]

  • 27. Transforming growth factor-beta induces selective increase of proteoglycan production and changes in the copolymeric structure of dermatan sulphate in human skin fibroblasts.
    Westergren-Thorsson G, Schmidtchen A, Särnstrand B, Fransson LA, Malmström A.
    Eur J Biochem; 1992 Apr 01; 205(1):277-86. PubMed ID: 1555588
    [Abstract] [Full Text] [Related]

  • 28. Tilorone-induced lysosomal storage mimicking the features of mucopolysaccharidosis and of lipidosis in rat liver.
    Lüllmann-Rauch R.
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1983 Apr 01; 44(3):355-68. PubMed ID: 6198800
    [Abstract] [Full Text] [Related]

  • 29. Development of tailor-made collagen-glycosaminoglycan matrices: EDC/NHS crosslinking, and ultrastructural aspects.
    Pieper JS, Hafmans T, Veerkamp JH, van Kuppevelt TH.
    Biomaterials; 2000 Mar 01; 21(6):581-93. PubMed ID: 10701459
    [Abstract] [Full Text] [Related]

  • 30. Small molecule inhibitors of protein interaction with glycosaminoglycans (SMIGs), a novel class of bioactive agents with anti-inflammatory properties.
    Harris N, Kogan FY, Il'kova G, Juhas S, Lahmy O, Gregor YI, Koppel J, Zhuk R, Gregor P.
    Biochim Biophys Acta; 2014 Jan 01; 1840(1):245-54. PubMed ID: 24060749
    [Abstract] [Full Text] [Related]

  • 31. Glycosaminoglycans in early chick embryo.
    Skandalis SS, Theocharis AD, Papageorgakopoulou N, Zagris N.
    Int J Dev Biol; 2003 May 01; 47(4):311-4. PubMed ID: 12755338
    [Abstract] [Full Text] [Related]

  • 32. Acridine Orange, a precipitant for sulfated glycosaminoglycans, causes mucopolysaccharidosis in cultured fibroblasts.
    Lüllmann-Rauch R, Ziegenhagen M.
    Histochemistry; 1991 May 01; 95(3):263-8. PubMed ID: 1904847
    [Abstract] [Full Text] [Related]

  • 33. The suramin-treated rat as a model of mucopolysaccharidosis: reversibility of biochemical and morphological changes in the liver.
    Rees S, Constantopoulos G, Brady R.
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1986 May 01; 51(3):235-45. PubMed ID: 2874656
    [Abstract] [Full Text] [Related]

  • 34. Activities of some glycosaminoglycan- degrading enzymes in Wharton's jelly and their alteration in EPH-gestosis (Pre-eclampsia).
    Romanowicz L, Bańkowski E, Sobolewski K, Jaworski S.
    Biol Neonate; 1999 Sep 01; 76(3):144-52. PubMed ID: 10460952
    [Abstract] [Full Text] [Related]

  • 35. Enhanced delivery of daidzein into fibroblasts and neuronal cells with cationic derivatives of gamma-cyclodextrin for the control of cellular glycosaminoglycans.
    Kamiński K, Kujdowicz M, Kajta M, Nowakowska M, Szczubiałka K.
    Eur J Pharm Biopharm; 2015 Apr 01; 91():111-9. PubMed ID: 25681746
    [Abstract] [Full Text] [Related]

  • 36. Physicochemical characteristics of the glycosaminoglycan-lysosomal enzyme interaction in vitro. A model of control of leucocytic lysosomal activity.
    Avila JL, Convit J.
    Biochem J; 1976 Nov 15; 160(2):129-36. PubMed ID: 12748
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. The effect of periodontal disease on sulphated glycosylaminoglycan distribution in the sheep periodontium.
    Kirkham J, Robinson C, Smith AJ, Spence JA.
    Arch Oral Biol; 1992 Dec 15; 37(12):1031-7. PubMed ID: 1471952
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Neural cells generated from human induced pluripotent stem cells as a model of CNS involvement in mucopolysaccharidosis type II.
    Rybová J, Ledvinová J, Sikora J, Kuchař L, Dobrovolný R.
    J Inherit Metab Dis; 2018 Mar 15; 41(2):221-229. PubMed ID: 29168031
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.